Another Blow Against Big PharmaTuesday, March 16, 2010
You know it’s really obvious when the mainstream calls out the dope therapy of Big Pharma as offering “no benefit.”
Doctors at the annual meeting of the American College of Cardiology in Atlanta on Sunday got some surprising news on their first day of sessions. Researchers presented three studies revealing that some of the most widely prescribed medications to reduce the risk of heart disease in Type 2 diabetes patients appeared not to provide much benefit at all.
In fact, the reports conclude that these drugs may even do more harm. And this was published in the New England Journal of Medicine, an ardent supporter of conventional, statist medicine. The power and influence of Big Pharma has been dwindling a bit, ever since the swine flu debacle happened. They’d better hurry up and get statins in the water. Thanks to Mark Fee for the link.